o f t h i s comnunication i s t o r e p o r t o u r preliminary findlngs in a 14 year o l d Haitian g i r l who developed insul
In-dependent DM a t age 6 y r s , g o i t e r a t 9 y r s , and p o l y a r t ic u l a r JRA a t 12 yrs.No evidence of l r i d o c y c l l t l s was present.Fo1-lowing thyrold and gold therapy t h e g o i t e r regressed and t h e a r t h r i t i s improved.There was a family h i s t o r y o f DM and g o i t e r ir the mother and of DM in maternal relatives.lnvestigations revealed normal T4;antlmicrosomal thyroid a n t i b o d i e s (1:25.000 and 1: 7,OOO);antinuclear a n t l b o d i e s (1:32.768 and l:1,024);rheumatoid f a c t o r (1:320 and 1:640);high-normal C3 (240mg%) and elevated C4 (240mg8) ;normal IgA and IgM,elevated 1gG;elevated gamma g l o b u l i n ; normal CBC peripheral smear and serum B12;normal adrenal response t o ACTH stimulation;HL-A.A-28,A-9,B-27,B-7,CW-2;eievated ESR (33 and 26 mn/hr) ; and evidence o f JRA on w r i s t x-ray.These findings a r e c o n s i s t e n t with the presence o f an autoimmune disorder. F u r t h e r m r e , t h e i r a s s o c i a t i o n with DH in t h i s p a t i e n t lends supp o r t t o t h e concept t h a t DM may i t s e l f be a d i s e a s e o f autoimnune origin.We b e l i e v e t h i s t o be the f l r s t report o f t h e coexistence and concurrent expression of DM, HT and JRA in one individual. A newly developed continuous glucose monitor (CGM) incorporates a non-thrombogenic blood withdrawal system and a glucose e l e c t r o d e which generates a continuous t r a c i n g of r e a l blood glucose (BG) during an Arginine-Insulin GH Stimulation Test (AIST) which was administered t o seven c h i l d r e n with s h o r t s t a tu r e .
The intravenous i n f u s i o n of a r g i n i n e was a s s o c i a t e d with an i n c r e a s e of BG from a b a s e l i n e of 83 + 10.9 t o 107.7 + 14.9 (mgl 100 m l + 1 SD). The peak l e v e l was reached 26.3 + 6.5 minutes, and returned t o b a s e l i n e 51.3 + 9.5 minutes, a f t e r t h e I V i n j e ct ion.
The n a d i r i n BG occurred 30.4 + 8.5 minutes a f t e r I V i n s u l i n . The b a s e l i n e l e v e l o f 76.6 + 10.1 mg1100 m l + 1 SD f e l l t o 29.15 6.2.
The BG returned t o normal 57.2 + 7.5 minutes a f t e r t h e I V i n j e c t i o n .
Symptoms of hypoglycemia may f o r c e premature termination of t h e AIST. I n two of the p a t i e n t s t h e A I S T was continued d e s p i t e symptoms because t h e BG l e v e l was increasing a t t h e time. The use of CGM i n c r e a s e s the s a f e t y of t h e AIST by providing r e a l t i m e l e v e l of BG.
ETABOLIC CLEARANCE RATE OF OXYTOCIN IN MATERNAL AND ETAL SHEEP. T.H. Glatz, R.E. Wei tzman, a t h a n i e l s z , and D.A. Fisher. Fetal-Maternal Research Laboratories, UCLA-Harbor General Hospital , Torrance, CA.
Simultaneous maternal and f e t a l plasma oxytocin (OXY) concn. (~U / m l ) were measured by radioimunoassay before and during continuous infusion of s y n t h e t i c OXY t o steady s t a t e conditions i n t o ewe o r f e t u s ( g e s t a t i o n a l age 124-140 days; a t l e a s t 5 days postsurgery; estimated f e t a l wt. 3 kg). 0.9'0.2 47.3'6.4 2.0t0.8 Fetal metabolic clearance r a t e s (MCR i n ml/kg/min) were calcul a t e d t o be 18.1 i 1.1 and 15.0 i 1.3 a t the two infusion r a t e s ; maternal MCR were 12.7 ? 2.8 and 13.4 i 2.3, r e s p e c t i v e l y . Exami n a t i o n of simultaneous f e t a l and maternal baseline OXY concent r a t i o n s revealed t h a t f e t a l l e v e l s were s i n i f i c a n t l y higher than maternal: 1 . 9 i 0 . 2 vs 0 . 7 t 0 . 1 (p<.05!.
Continuous m n it o r i n g o f u t e r i n e pressure revealed t h a t u t e r i n e contractions were induced by maternal i n f u s i o n of 800 vU/kg/min; no u t e r i n e c o n t r a c t i o n s were induced by f e t a l infusion. Conclusions based on these data a r e : 1 ) plasma OXY l e v e l s exceed maternal l e v e l s i n f e t u s e s o f 124-140 days g e s t a t i o n ; 2 ) transplacental passage o f OXY i s minimal i n both M-F and F-M d i r e c t i o n s ; 3) maternal and f e t a l MCR of OXY a r e s i m i l a r and unrelated t o plasma OXY l e v e l s .
A NEW SYNDROME OF SHORT STATURE BLIT IMMLTNOREACTIVE GROWTH HORMONE, Alberto T. Peake and Robert E. Greenber Depts. of New Mexico School of Med.. Albuquerque, New Mexico.
A 25 month old g i r l was f i r s t seen because of growth decelerat i o n beginning a t 3 months of age. B i r t h weight was 6% l b s . and length 19". P. examination was normal except f o r a height-age of 1 3 months. After estrogen priming a growth hormone (GH) s t i m u l a t i o n t e s t following s e q u e n t i a l L-Dopa, a r g i n i n e and glucagon peaked a t 124 nglml from a base-line of 63 nglml. Serum somatomedin-C (Sm-C) concentration, both b a s a l and post-stimulat i o n , measured 0.24 U l m l . (Nl. 1 . 5 5 . 5 U/ml. Measured by Dr. L. Underwood, Univ. of North Carolina, Chapel H i l l ) . A t t h e end of a 24 hour f a s t her blood glucose was 68 mg%. GH was given f o r 6 days and h e r Sm-C l e v e l increased t o 0.43 U/ml. Four months l a t e r h e r metabolic response t o the administration of GH f o r 6 days showed: re1ea.e of FFA from 757 t o 1341 uM/1 and no inc r e a s e i n urinary Caw. Again h e r Sm-C increased from 0.19 t o a peak of .73 U/ml. P r i o r t o GH, h e r b a s a l GH l e v e l s ranged from I 8 t o 14 ng/ml. By RIA h e r GH produced a p a r a l l e l dose-response I t o p i t u i t a r y GH standard. A f t e r t h e above s t u d y , t h e p a t i e n t , was discharged on GH, 0 . 1 U/kg t h r e e times a week. I n t h e l a s t 1 2 months h e r growth r a t e has increased from 0.5 t o llcmlmonth. j The data on t h i s p a t i e n t appear t o r u l e out a d e f e c t i n Sm-C I s y n t h e s i s o r f u n c t i o n , a s w e l l a s f a c t o r s , e i t h e r i n h i b i t i n g GH a c t i o n o r r e c e p t o r function. The growth d e c e l e r a t i o n could be explained on t h e b a s i s of an abnormal c i r c u l a t i n g GH molecule. Pregnant rhesus monkeys(120-145 days) were a n e s t h e t i z e d with Ketamine, and a femoral maternal a r t e r y c a t h e t e r and f e t a l umb i l i c a l a r t e r y and/or e i n were cannulated b an extra-amniotic technique. E i t h e r @L-lyg DES, b n o e t h y l -1 -3dDES o r %,7 ,3H' EZ i n 0% ethanol was given in a maternal vein. Blood samples were col ected f o r a 2 h r period. The maternal T+ f o r t h e 1%-OES was 35 in a s compared t o 100 min f o r 3~ DES. The TL, f o r E2 was 45 min. 0 t h DES and E2 appeared in t h e f e t a l c i r c u l a t i o n within 5min and eached a maximum t o t a l r a d i o a c t i v i t y a t 40-60 min. R a d i o a c t i v i t j ccumulated primarily i n f e t a l l i v e r , l u n g , i n t e s t i n e , uterus and r a i n of animals d i s s e c t e d immediately a f t e r t h e experiment. Coml e t e a n a l y s i s was performed on t h e t o t a l f e c a l and urinary prou c t s i n one animal. Urinary conjugates were p u r i f i e d by XAD-2 nd Sephadex LH-20(MEOH/ETOH 1 : l ) . Three urinary conjugate f r a cions were obtained, hydrolyzed, and t h e aglycones i d e n t i f i e d by C/MS t o be c i s / t r a n s DES and possibly d i e n e s t r o l . The principal ecal p r o d u c t o~f t e r e x t r a c t i o n and LH-20 purification(benzne/MEOH 80:20) was i d e n t i f i e d thru GC/MS a s DES. The f e c a l con-
